Between abnormalities with income, employment verification and legal status in the U.S., it appears as though the bulk of Obamacare enrollees are either criminals, deadbeats or unlawful aliens who don’t actually belong in the united states. Of the roughly 8 million applicants who have signed up for Obamacare as of this writing, almost 3 million of them cannot be verified by the existing system as eligible, according to the HHS. And at this point in time, there is no real method to ever verify them, as admitted by the Inspector General, further proving the substantial swindle that is levied on the American people by the Usurper-in-Chief who, ironically, has his personal eligibility inconsistencies. Four state-work exchanges admit they will have no way of verifying if Obamacare enrollees are legal citizens Beyond the federal government debacle, at least four state-run Obamacare exchanges are also not capable of verifying applicant eligibility.Preventing thrombosis is a significant therapeutic goal in sufferers with the antiphospholipid syndrome. However, despite sufficient anticoagulation, renal lesions develop in a few individuals6,7 and recur after transplantation, leading to graft loss often.9 Our data claim that inhibition of the mTORC pathway in kidney-transplant recipients who’ve antiphospholipid antibodies defends the transplanted graft and, more important, prevents graft loss by avoiding the advancement of intimal hyperplasia. We observed that the degrees of antiphospholipid antibodies and the immunologic variables known to affect graft survival were very similar in the transplant recipients, irrespective of whether they were receiving sirolimus, an observation that rules out a particular effect of sirolimus on the immune system, as previously reported in some immunologic disorders.34,35 In addition, we discovered that the beneficial effect of sirolimus was independent of coagulation, since all of the transplant recipients with antiphospholipid antibodies had adequate anticoagulation.